Applications of Flow Cytometry in the Drug Development Process
Learning Objectives
- Introduction to the principles of flow cytometry and what makes it a powerful analytical technology
- Review key areas across the drug development pathway supported by flow cytometry assays
- Highlight key requirements when developing flow cytometry assays
- Review emerging technology areas and possible future trends
Webinar Description
Flow Cytometry has many applications in clinical development allowing rapid and highly specific characterization of cells. In recent years, flow cytometry techniques have established a foothold in preclinical and clinical drug development providing an ability to identify and characterize cell lineage, morphology, activation status and a host of other parameters. The technology can provide critical, high data-resolution insights when evaluating and measuring biological activity and functional endpoints. This webinar will provide an insight into the current applications of flow cytometry in the drug development process, and examine new technologies for the future.
Meet the Speakers
 |
David Lanham, MSc, CBiol, MRSB David Lanham, is Principal Scientific Director at Eurofins Pharma Bioanalysis group, Oxford, UK. He has worked in a wide range of areas within the pharmaceutical CRO industry in the UK for over 25 years, including roles in cell-based assay modelling, pre-clinical toxicology assessment and clinical trial bioanalysis. During this time he has developed an interest and expertise around immune function assessment and biomarker analysis. His current role in Oxford focuses on the application of flow cytometry and ligand binding techniques as investigative tools in bioanalysis during pharmaceutical drug development and is a member of the AAPS Flow Cytometry Action Program Committee. |
